pat
On Fri, Feb 25, 2011 at 2:38 PM, Mahina <mahinaj4@hotmail.com> wrote:
I have a lady that would like more information on what she could do
for her endometrial adenocarcinoma.
Would you do the cancer protocol?? Or is there a "simpler" approach to
this one I could suggest first??
Also, is there an "oils" website I could research some of this on
myself that I don't know about?
Thanks!
Background
Carcinoma of the endometrium is among the most common female pelvic
malignancies and may develop in normal, atrophic, or hyperplastic
endometrium. Most of the cancers are detected at an early stage, with
the tumor confined to the uterine corpus in 75% of patients. The
prognosis generally is favorable.
Here are some risk factors I came across for this condition.
Multiple risk factors associated with endometrial cancer include
conditions associated with disorders of menstruation, increased
perimenopausal bleeding, menopause after age 52 years, long time
period between menarche and menopause, estrogen replacement therapy,
tamoxifen therapy for breast cancer, endometrial hyperplasia, obesity,
nulliparity, diabetes mellitus, and hypertension. Genetic
predisposition appears to play a role, since risk factors also include
a family history of endometrial or breast cancer and a personal
history of ovarian or breast cancer.
--
You received this message because you are subscribed to the Google
Groups "Everything doTERRA" group.
To post to this group, send email to everythingdoterra@googlegroups.com
To unsubscribe from this group, send email to
everythingdoterra+unsubscribe@googlegroups.com
For more options, visit this group at
http://www.everythingdoterra.com
--
PAT LEAVITT
FOUNDING DIAMOND CONSULTANT
--
You received this message because you are subscribed to the Google
Groups "Everything doTERRA" group.
To post to this group, send email to everythingdoterra@googlegroups.com
To unsubscribe from this group, send email to
everythingdoterra+unsubscribe@googlegroups.com
For more options, visit this group at
http://www.everythingdoterra.com
No comments:
Post a Comment